Novel Neuroprotective Mechanisms of Memantine: Increase in Neurotrophic Factor Release from Astroglia and Anti-Inflammation by Preventing Microglial Activation
暂无分享,去创建一个
Hung-Ming Wu | Ru-Band Lu | R. Lu | Xiaoming Hu | Sung-Jen Wei | Shih-Heng Chen | Jau-Shyong Hong | L. Qian | Nian-Sheng Tzeng | Jau-Shyong Hong | Shih-Heng Chen | Nian-Sheng Tzeng | Li Qian | Sung-Jen Wei | Xiaoming Hu | Scott M Rawls | Patrick Flood | S. Rawls | Hung-Ming Wu | P. Flood
[1] H. Ushijima,et al. HIV-1 gp120 and NMDA induce protein kinase C translocation differentially in rat primary neuronal cultures. , 1993, Journal of Acquired Immune Deficiency Syndromes.
[2] Yue Huang,et al. Genetic contributions to Parkinson's disease , 2004, Brain Research Reviews.
[3] J. Rogers,et al. Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder? , 2007, International review of neurobiology.
[4] M. Vila,et al. Pathogenic role of glial cells in Parkinson's disease , 2003, Movement disorders : official journal of the Movement Disorder Society.
[5] R. Tennant,et al. 12-O-Tetradecanoylphorbol-13-acetate and UV Radiation-induced Nucleoside Diphosphate Protein Kinase B Mediates Neoplastic Transformation of Epidermal Cells* , 2004, Journal of Biological Chemistry.
[6] J. McGinty,et al. l‐trans‐Pyrrolidine‐2,4‐Dicarboxylic Acid‐Evoked Striatal Glutamate Levels Are Attenuated by Calcium Reduction, Tetrodotoxin, and Glutamate Receptor Blockade , 1997, Journal of neurochemistry.
[7] Bin Liu,et al. NADPH Oxidase Mediates Lipopolysaccharide-induced Neurotoxicity and Proinflammatory Gene Expression in Activated Microglia* , 2004, Journal of Biological Chemistry.
[8] S. Lipton,et al. The chemical biology of clinically tolerated NMDA receptor antagonists , 2006, Journal of neurochemistry.
[9] M. Merello,et al. Effect of memantine (NMDA antagonist) on Parkinson's disease: a double-blind crossover randomized study. , 1999, Clinical neuropharmacology.
[10] M. Weller,et al. MK-801 and memantine protect cultured neurons from glutamate toxicity induced by glutamate carboxypeptidase-mediated cleavage of methotrexate. , 1993, European journal of pharmacology.
[11] B. Liu,et al. Inhibition by Naloxone Stereoisomers of β-Amyloid Peptide (1–42)-induced Superoxide Production in Microglia and Degeneration of Cortical and Mesencephalic Neurons , 2002, Journal of Pharmacology and Experimental Therapeutics.
[12] Steven A. Johnson,et al. BDNF mRNA is decreased in the hippocampus of individuals with Alzheimer's disease , 1991, Neuron.
[13] Masahiko Watanabe,et al. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. , 1997, Science.
[14] B. Liu,et al. Distinct Role for Microglia in Rotenone-Induced Degeneration of Dopaminergic Neurons , 2002, The Journal of Neuroscience.
[15] P. Marks,et al. Structures of a histone deacetylase homologue bound to the TSA and SAHA inhibitors , 1999, Nature.
[16] F. Crews,et al. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration , 2007, Glia.
[17] C. Darlington. Astrocytes as targets for neuroprotective drugs. , 2005, Current opinion in investigational drugs.
[18] Chris G. Parsons,et al. Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system - too little activation is bad, too much is even worse , 2007, Neuropharmacology.
[19] Bin Liu,et al. Role of Microglia in Inflammation-Mediated Neurodegenerative Diseases: Mechanisms and Strategies for Therapeutic Intervention , 2003, Journal of Pharmacology and Experimental Therapeutics.
[20] B. Liu,et al. Primary rat mesencephalic neuron-glia, neuron-enriched, microglia-enriched, and astroglia-enriched cultures. , 2003, Methods in molecular medicine.
[21] L. Buée,et al. Neurotrophic factors in Alzheimer’s disease: role of axonal transport , 2008, Genes, brain, and behavior.
[22] M. Caraglia,et al. Acetylation of proteins as novel target for antitumor therapy: Review article , 2004, Amino Acids.
[23] S. Lipton. Paradigm shift in neuroprotection by NMDA receptor blockade: Memantine and beyond , 2006, Nature Reviews Drug Discovery.
[24] M. Murer,et al. Brain-derived neurotrophic factor in the control human brain, and in Alzheimer’s disease and Parkinson’s disease , 2001, Progress in Neurobiology.
[25] C. Parsons,et al. The NMDA receptor antagonist memantine as a symptomatological and neuroprotective treatment for Alzheimer's disease: preclinical evidence , 2003, International journal of geriatric psychiatry.
[26] Bin Liu,et al. Microglia enhance β‐amyloid peptide‐induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species , 2002 .
[27] G. Li,et al. Nanometer size diesel exhaust particles are selectively toxic to dopaminergic neurons: the role of microglia, phagocytosis, and NADPH oxidase , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[28] D. Chuang,et al. Histone deacetylase inhibitors up-regulate astrocyte GDNF and BDNF gene transcription and protect dopaminergic neurons. , 2008, The international journal of neuropsychopharmacology.
[29] M. Block,et al. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms , 2007, Nature Reviews Neuroscience.
[30] Timothy Sendera,et al. Clinicopathological findings following intraventricular glial‐derived neurotrophic factor treatment in a patient with Parkinson's disease , 1999, Annals of neurology.
[31] P. Gean,et al. Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes , 2006, Molecular Psychiatry.
[32] C. Barnes,et al. Memantine protects against LPS-induced neuroinflammation, restores behaviorally-induced gene expression and spatial learning in the rat , 2006, Neuroscience.
[33] R. Dempsey,et al. Protective Effects of Memantine Against Ischemia-Reperfusion Injury in Spontaneously Hypertensive Rats , 1999, Acta Neurochirurgica.
[34] T. Jay,et al. Excitotoxicity in neurological disorders — the glutamate paradox , 2000, International Journal of Developmental Neuroscience.
[35] Leif Hertz,et al. Astrocytic control of glutamatergic activity: astrocytes as stars of the show , 2004, Trends in Neurosciences.
[36] G. Wilcock,et al. A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500) , 2002, International clinical psychopharmacology.
[37] R. Arantes,et al. A Role for Synaptotagmin VII-Regulated Exocytosis of Lysosomes in Neurite Outgrowth from Primary Sympathetic Neurons , 2006, The Journal of Neuroscience.
[38] S. Lipton. Pathologically-activated therapeutics for neuroprotection: mechanism of NMDA receptor block by memantine and S-nitrosylation. , 2007, Current drug targets.
[39] L. V. Van Eldik,et al. Glia as a Therapeutic Target: Selective Suppression of Human Amyloid-β-Induced Upregulation of Brain Proinflammatory Cytokine Production Attenuates Neurodegeneration , 2006, The Journal of Neuroscience.
[40] P. Toth,et al. In vitro galantamine-memantine co-application: Mechanism of beneficial action , 2006, Neuropharmacology.
[41] L. V. Van Eldik,et al. P4-428 Glia as a therapeutic target: Selective suppression of human amyloid-beta-induced upregulation of brain proinflammatory cytokine production attenuates neurodegeneration , 2006, Alzheimer's & Dementia.
[42] M. Weller,et al. NMDA receptor-mediated glutamate toxicity of cultured cerebellar, cortical and mesencephalic neurons: neuroprotective properties of amantadine and memantine , 1993, Brain Research.
[43] M. Block,et al. Microglia and inflammation-mediated neurodegeneration: Multiple triggers with a common mechanism , 2005, Progress in Neurobiology.
[44] J. Roh,et al. Memantine Reduces Hematoma Expansion in Experimental Intracerebral Hemorrhage, Resulting in Functional Improvement , 2006, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[45] C. Parsons,et al. Potential role of N-methyl-D-aspartate receptors as executors of neurodegeneration resulting from diverse insults: focus on memantine. , 2006, Behavioural pharmacology.
[46] S. Barger,et al. Glutamate release from activated microglia requires the oxidative burst and lipid peroxidation , 2007, Journal of neurochemistry.
[47] Tony Wyss-Coray,et al. Inflammation in Alzheimer disease: driving force, bystander or beneficial response? , 2006, Nature Medicine.
[48] H. Ushijima,et al. Cytoprotective effect of NMDA receptor antagonists on prion protein (PrionSc)-induced toxicity in rat cortical cell cultures. , 1993, European journal of pharmacology.
[49] J. Jankovic,et al. Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD , 2003, Neurology.
[50] J. Lile,et al. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. , 1993, Science.
[51] W. Danysz,et al. The cytotoxicity of chronic neuroinflammation upon basal forebrain cholinergic neurons of rats can be attenuated by glutamatergic antagonism or cyclooxygenase-2 inhibition , 2000, Experimental Brain Research.
[52] Akio Suzumura,et al. Neuritic Beading Induced by Activated Microglia Is an Early Feature of Neuronal Dysfunction Toward Neuronal Death by Inhibition of Mitochondrial Respiration and Axonal Transport* , 2005, Journal of Biological Chemistry.
[53] J. Nutt,et al. Treatment of Parkinson’s disease with trophic factors , 2008, Neurotherapeutics.
[54] P. Bickford,et al. Brain-Derived Neurotrophic Factor Is Required for the Establishment of the Proper Number of Dopaminergic Neurons in the Substantia Nigra Pars Compacta , 2005, The Journal of Neuroscience.
[55] Bin Liu,et al. Microglia enhance beta-amyloid peptide-induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species. , 2002, Journal of neurochemistry.
[56] P. Gean,et al. Valproic acid and other histone deacetylase inhibitors induce microglial apoptosis and attenuate lipopolysaccharide-induced dopaminergic neurotoxicity , 2007, Neuroscience.
[57] E. Hermans,et al. Specific regulation of rat glial cell line‐derived neurotrophic factor gene expression by riluzole in C6 glioma cells , 2006, Journal of neurochemistry.
[58] E. Hermans,et al. Amantadine and memantine induce the expression of the glial cell line-derived neurotrophic factor in C6 glioma cells , 2006, Neuroscience Letters.
[59] M. Riepe,et al. Memantine in Moderate-to-severe Alzheimer's Disease , 2006 .
[60] Melina V Jones,et al. Synergistic neurotoxicity by human immunodeficiency virus proteins Tat and gp120: Protection by memantine , 2000, Annals of neurology.